Cell type-specific methylation of an intronic CpG island controls expression of the MCJ gene

Carcinogenesis

Volumn 25, Issue 5, 2004, Pages 693-701

  Strathdee, G ^d   Davies, B R ^a   Vass, J K ^b   Siddiqui, N ^c   Brown, R ^d  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^c STOBHILL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; CISPLATIN; HISTONE; PROTEIN DNAJ;

ACETYLATION; ARTICLE; CANCER CELL CULTURE; CANCER RESISTANCE; CELL SPECIFICITY; CELL TYPE; CHROMATIN; CHROMATIN STRUCTURE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; EPITHELIUM CELL; EXON; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENE LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOPRECIPITATION; INTRON; LYMPHOCYTE; OVARY CANCER; PRIORITY JOURNAL; PROMOTER REGION;

ACETYLATION; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CHROMATIN; CISPLATIN; CPG ISLANDS; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAT-SHOCK PROTEINS; HISTONE DEACETYLASES; HISTONES; HSP40 HEAT-SHOCK PROTEINS; HUMANS; INTRONS; LYMPHOCYTES; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; OVARY; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 2442443111     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh066     Document Type: Article

References (25)

1. Bird,A. (1996) The relationship of DNA methylation to cancer. Cancer Surv., 28, 87-101.
2. Costello,J.F and Plass,C. (2001) Methylation matters. J. Med. Genet., 38, 285-303.
3. Bird,A. and Wolffe,A.P. (1999) Methylation-induced repression - belts, braces and chromatin. Cell, 99, 451-454.
4. Holliday,R. and Pugh,J.E. (1975) DNA modification mechanisms and gene activity during development. Science, 187, 226-232.
5. Jones,P.A. and Takai,D. (2001) The role of DNA methylation in mammalian epigenetics. Science, 293, 1068-1070.
6. Futscher,B.W., Oshiro,M.M., Wozniak,R.J., Holtan,N., Hanigan,C.L., Duan,H. and Domann,F.E. (2002) Role for DNA methylation in the control of cell type-specific maspin expression. Nature Genet., 31, 175-179.
7. Shridhar,V., Bible,K.C., Staub,J., Avula,R., Lee,Y.K., Kalli,K., Huang,H., Hartmann,L.C., Kaufmann,S.H. and Smith,D.I. (2001) Loss of expression of a new member of the DNAJ protein family confers resistance to chemotherapeutic agents used in the treatment of ovarian cancer. Cancer Res., 61, 4258-4265.
8. Edmondson,R.J., Monaghan,J.M. and Davies,B.R. (2002) Human surface epithelium is an androgen responsive tissue. Br. J. Cancer, 86, 879-885.
9. Strathdee,G., MacKean,M., Illand,M. and Brown,R. (1999) A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer. Oncogene, 18, 2335-2341.
10. Anthoney,D.A., McIlwrath,A.J., Gallagher,W.M., Edlin,A.R.M. and Brown,R. (1996) Microsatellite instability, apoptosis and loss of p53 function in drug resistant tumour cells. Cancer Res., 56, 1374-1381.
11. Xiong,Z. and Laird,P.W. (1997) COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res., 25, 2532-2534.
12. Auersperg,N., Wong,A.S.T., Choi,K.C., Kang,S.K. and Leung,P.C.K. (2001) Ovarian surface epithelium: biology, endocrinology and pathology. Endocr. Rev., 22, 255-288.
13. Lee,P.P., Fitzpatrick,D.R., Beard,C. et al. (2001) A critical role for DNMT1 and DNA methylation in T cell development, function and survival. Immunity, 15, 763-774.
14. Makar,K.W., Perez-Melgosa,M., Shnyreva,M., Weaver,W.M., Fitzpatrick,D.R and Wilson,C.B. (2003) Active recruitment of DNA methyltransferases regulate interleakin 4 in thymocytes and T cells. Nature Immunol., 4, 1183-1190.
15. Hutchins,A.S., Mullen,A.C., Lee,H.W., Sykes,K.J., High,F.A., Hendrich,B.D., Bird,A.P. and Reiner,S.L. (2002) Gene silencing quantitatively controls the function of a developmental trans-activator. Mol. Cell, 10, 81-91.
16. Takai,D. and Jones P.A. (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl Acad. Sci. USA, 99, 3740-3745.
17. Hsieh,C.L. (1997) Stability of patch methylation and its impact in regions of transcriptional initiation and elongation. Mol. Cell. Biol., 17, 5897-5904.
18. Curradi,M., Izzo,A., Badaracco,G. and Landsberger,N. (2002) Molecular mechanisms of gene silencing mediated by DNA methylation. Mol. Cell. Biol., 22, 3157-3173.
19. Kass,S.U., Goddard,J.P. and Adams,R.L. (1993) Inactive chromatin spreads from a focus of methylation. Mol. Cell. Biol., 13, 7372-7379.
20. Gonzalez-Zulueta,M., Bender,C.M., Yang,A.S., Nguyen,T., Beart,R.W., Van Tornout,J.M. and Jones,P.A. (1995) Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55, 4531-4535.
21. Ferguson,A.T., Evron,E., Umbricht,C.B. et al. (2000) High frequency of hypermethylation of the 14-3-3 sigma locus leads to gene silencing in breast cancer. Proc. Natl Acad. Sci. USA, 97, 6049-6054.
22. Pao,M.M., Tsutsumi,M., Liang,G., Uzvolgyi,E., Gonzales,F.A. and Jones,P.A. (2001) The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumour cells. Hum. Mol. Genet., 10, 903-910.
23. Strathdee,G., Appleton,K., Illand,M., Millan,D.W.M., Sargent,J., Paul,J. and Brown,R. (2001) Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am. J. Pathol., 158, 1121-1127.
24. Wei,S.H., Brown,R. and Huang,T.H. (2003) Aberrant DNA methylation in ovarian cancer: is there an epigenetic predisposition to drug response? Ann. N. Y. Acad. Sci., 983, 243-50.
25. Plumb,J.A., Stradidee,G., Sludden,J., Kaye,S.B. and Brown,R. (2000) Reversal of drug resistance in human tumour xenografts by 2′-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter. Cancer Res., 60, 6039-6044.